Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
The drug company Roche, which makes Tamiflu, has announced it will give researchers access to all its trial data for the influenza drug, the BMJ reports.
Roche had previously been criticised for failing to grant access to the results of all its 74 trials.
In an email it said it would provide the information over the next few months.
Campaigners say Roche should not have delayed access to the data.
It is estimated that half of all clinical trials have never been published and positive trial results are twice as likely to be published as negative findings.
http://www.bbc.co.uk/news/health-22029708
Roche had previously been criticised for failing to grant access to the results of all its 74 trials.
In an email it said it would provide the information over the next few months.
Campaigners say Roche should not have delayed access to the data.
It is estimated that half of all clinical trials have never been published and positive trial results are twice as likely to be published as negative findings.
http://www.bbc.co.uk/news/health-22029708